Tagged with spain

Spain Sergio Serra Ripol, managing director of Tillotts Pharma Spain, highlights the challenges associated with setting up the affiliate and the strategic importance of Spain as Tillotts grows its European footprint. Furthermore, he gives an insight into the importance of relationships in building the company’s network and his vision for the…

Spain Melqui Calzado, general secretary of Catalonia Bio and Health Tech, highlights the association’s strategy to establish the region as an international reference centre for innovation and entrepreneurship, as well as giving an overview of the steps required to see a new wave of Catalan pharmaceutical companies.   Many large international…

Spain Juan Luis Fernández Balaguer, general manager of Laboratorios Combix, the Spanish affiliate of Zydus Cadila, shares the milestones achieved by the company since joining the group and its promising future as one of two European operations. Having formerly served as president of AESEG, he then goes on to offer expert…

Spain Giuseppe Chiericatti of Chiesi Spain talks strategy, the development of the affiliate and shifting attitudes towards rare diseases in Spain.   Social responsibility and sustainability is a key part of our mission. Our goal is to integrate the concept of sustainability in whatever we do You’ve been leading the Spanish…

Spain Jesús Fernández-Pacheco Mena, country manager of hmR Spain, a health market research specialist, highlights the innovative “sell out” model of obtaining market data and the strategy in place to change the industry´s mindset to utilize this information. Furthermore, he highlights the services they provide and how this will evolve in…

Spain Ruth Vera highlights how the Spanish Society of Medical Oncology (SEOM) works to be the premier partner in the Spanish oncology ecosystem and the main cancer problems Spain is currently experiencing. Furthermore, she suggests how Spain can improve its oncology care and her aspirations for the future.   As in…

Spain Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how remaining independent in the face of industry consolidation is a strategic priority to leverage both quality and specialization for the company’s clients.   When[biosimilars] come…

Spain Luis Campo, CEO of GE Healthcare Spain & Portugal, discusses the opportunities and challenges inherent in the Spanish healthcare system and the ways in which GE is collaborating with authorities to bring innovative solutions to Spanish patients.   GE Healthcare is pioneering the concept of a hospital Command Centre, learning…

Spain Luis Maria de Palacio Guerrero, president of the Federacion Empresarial de Farmaceuticos Españoles (FEFE) lifts the lid on plans to reunite the regional affiliates under the national FEFE umbrella. He also discusses the impact of independent pharmacies in Spain and the future challenges for such a system, in particular, the…

Spain Luis Serrano, president of the Centre for Genomic Regulation (CRG) in Spain, gives an update on the Centre’s recent history and outlines the need for greater understanding of science and research within the Spanish political class.   When we enter discussions with the different political parties, I feel things are…

Spain Carlos Rubió, executive president of Laboratorios Rubió, gives an overview of the company’s early years and his priorities now to make the company a larger player on the international scene. Furthermore, he highlights the need to increase the company´s size through JVs, possible M&As and US expansion, as well as…

Spain Jordi Naval, CEO of Biocat, describes the evolution of the BioRegion of Catalonia as an increasingly relevant biotechnology hub in Spain and Europe. Naval also elaborates on the role of Biocat in tackling the challenge of translating basic research into functional innovation which can impact the healthcare ecosystem.   Now,…